Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 11
Submit an article Journal homepage
347
Views
3
CrossRef citations to date
0
Altmetric
Psychiatry: Brief report

Real-world use patterns of olanzapine long-acting injection in the United States: comparison to the recommended dosing strategy

Michael G. CaseEli Lilly and Company, Indianapolis INUSACorrespondence[email protected]
,
Jamie L. KaragianisLilly USA, LLC, Indianapolis INUSA;Memorial University of Newfoundland, St. John’s, Newfoundland and LabradorCanada;Waypoint Centre for Mental Health Care, Penetanguishene ONCanada
,
Kory J. SchuhEli Lilly and Company, Indianapolis INUSA
&
Vicki Poole HoffmannLilly USA, LLC, Indianapolis INUSA
Pages 1533-1537 | Accepted 14 Aug 2013, Published online: 06 Sep 2013

References

  • Velligan DI, Lam F, Ereshefsky L, Miller AL. Psychopharmacology: perspectives on medication adherence and atypical antipsychotic medications. Psychiatr Serv 2003;54:665-7
  • Chue P. Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic. Neuropsychiatr Dis Treat 2007;3:13-39
  • American Psychiatric Association. Practice Guideline for the Treatment of Patients with Schizophrenia, 2nd edn. Arlington: American Psychiatric Association, 2004
  • The NICE Guideline on Core Intervention in the Treatment and Management of Schizophrenia in Adults in Primary and Secondary Care (Updated Edition). National Clinical Guideline Number 82. London: The British Psychological Society & The Royal College of Psychiatrists, 2010. Available at: http://guidance.nice.org.uk/CG82/Guidance/pdf/English [Last accessed 6 September 2011]
  • Leucht C, Heres S, Kane JM, et al. Oral versus depot antipsychotic drugs for schizophrenia – a critical systematic review and meta-analysis of randomized long-term trials. Schizophr Res 2011;127:83-92
  • Lauriello J, Lambert T, Andersen S, et al. An 8-week, double-blind, randomized, placebo-controlled study of olanzapine long-acting injection in acutely ill patients with schizophrenia. J Clin Psychiatry 2008;69:790-9
  • Kane JM, Detke HC, Naber D, et al. Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia. Am J Psychiatry 2010;167:181-9
  • Zyprexa Relprevv Patient Care Program. Lilly LLC, USA. Available at: https://zyprexarelprevvprogram.com/public/default.aspx [Last accessed 11 April 2012]
  • Detke HC, McDonnell DP, Brunner E, et al. Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases. BMC Psychiatry 2010;10:43
  • Flanagan RJ. Fatal toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp 2008;23:43-51
  • Saar E, Beyer J, Gerostamoulos D, Drummer OH. The time-dependant post-mortem redistribution of antipsychotic drugs. Forensic Sci Int 2012;222:223-7

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.